Istituto Oncologico Veneto Irccs
Clinical trials sponsored by Istituto Oncologico Veneto Irccs, explained in plain language.
-
New attack on deadly cancer: powerful drug combo before surgery
Disease control OngoingThis study is testing whether adding an immunotherapy drug (pembrolizumab) to standard chemotherapy before surgery helps fight pleural mesothelioma more effectively. It involves 41 adults with early-stage, operable mesothelioma who haven't had prior cancer treatment. Patients rec…
Phase: PHASE2 • Sponsor: Istituto Oncologico Veneto IRCCS • Aim: Disease control
Last updated Mar 23, 2026 15:19 UTC
-
New blood test aims to spot more lung cancer clues
Diagnosis OngoingThis study is testing a new blood test to see if it can find more genetic mutations linked to lung cancer than the current standard test. It involves 130 adults with advanced lung cancer who have already had the standard test. The goal is to see if this new method is better at de…
Phase: NA • Sponsor: Istituto Oncologico Veneto IRCCS • Aim: Diagnosis
Last updated Apr 01, 2026 14:41 UTC
-
Virtual reality goggles aim to ease pain and fear for cancer patients
Symptom relief ENROLLING_BY_INVITATIONThis study is testing if wearing virtual reality (VR) goggles can help reduce anxiety and pain for adult cancer patients getting a PICC line or port placed for treatment. 120 patients will be randomly assigned to either receive the VR experience during the procedure or to receive…
Phase: NA • Sponsor: Istituto Oncologico Veneto IRCCS • Aim: Symptom relief
Last updated Apr 02, 2026 14:57 UTC
-
Scientists scan brains to unlock Tumor's immune secrets
Knowledge-focused OngoingThis study aims to understand how aggressive brain tumors (gliomas) suppress the body's immune system. Researchers will use special MRI and PET scans on 31 adult patients to look for specific signs of immune suppression within the tumor. The goal is to gather knowledge about the …
Sponsor: Istituto Oncologico Veneto IRCCS • Aim: Knowledge-focused
Last updated Apr 04, 2026 02:21 UTC